Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.
Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.
Interferon beta-1b
Effirma, Synthetic Biologics
The force awakens: insights into the origin and formation of microglia.
Impact of Disease-Modifying Therapies on the Survival of Patients with Multiple Sclerosis in Taiwan, 1997-2008.
Novel MS Drugs Advance
Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.
Phase IV, Rater-blinded, Randomized Study, Comparing the Effects of 250 mg of Betaseron With 20 mg of Copaxone in Patients With the Relapsing-remitting or Clinically Isolated Forms of Multiple Sclerosis Using 3 Tesla MRI With Triple-dose Gadolinium
[Flow cytometry model for the detection of neutralizing antibodies against of IFN-β].
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.
Therapy Optimization in Multiple Sclerosis: A cohort study of therapy adherence and risk of relapse.
Checklist for reporting and reviewing studies of experimental animal models of multiple sclerosis and related disorders.
Fingolimod versus interferon beta/glatiramer acetate after natalizumab suspension in multiple sclerosis.
Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
Validation of the Brazilian version of the neurological fatigue index for multiple sclerosis.
Gene Expression Profiles of Autophagy-Related Genes in Multiple Sclerosis.
CCL genes in multiple sclerosis and systemic lupus erythematosus.
Mechanisms of action for treatments in multiple sclerosis: Does a heterogeneous disease demand a multi-targeted therapeutic approach?
Genes associated with T helper 17 cell differentiation and function.
Influence of infection on exacerbations of multiple sclerosis.
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada) in Multiple Sclerosis
Long-term efficacy and safety of transanal irrigation in multiple sclerosis.
The effectiveness of dimethyl fumarate monotherapy in the treatment of relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Acorda Therapeutics announces Hatch-Waxman extension of AMPYRA® (dalfampridine) sustained-release formulation patent

Pages